Pharmaceutical company fined 68 million UZS for counterfeit Imudon production

A company involved in the production of a counterfeit version of the medicine Imudon has been fined 68 million UZS.

Abbott Products Operations AG filed a complaint with the Ministry of Justice against the manufacturer of the counterfeit version of its drug Imudon.

During an inspection of the enterprise "LLC A," it was discovered that a product under the name Nest Imudon was being produced, which closely resembled the original Imudon drug.

It is noted that the director of "LLC A," S.F., had previously been held administratively liable for the production and sale of a counterfeit version of the drug Magne B6. As a result, "LLC A" was fined 68 million UZS.